- Home
- TARS vs SRPT Comparison
TARS vs SRPT Comparison
Compare TARS & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | SRPT |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.3B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | TARS | SRPT |
|---|---|---|
| Price | $81.11 | $22.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 29 |
| Target Price | ★ $76.56 | $26.23 |
| AVG Volume (30 Days) | 404.5K | ★ 3.6M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $366,100,000.00 | ★ $2,413,715,000.00 |
| Revenue This Year | $147.24 | $13.83 |
| Revenue Next Year | $53.11 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 182.44 | 47.15 |
| 52 Week Low | $38.51 | $10.42 |
| 52 Week High | $85.25 | $129.84 |
Technical Indicators
Market Signals| Indicator | TARS | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 59.46 | 58.69 |
| Support Level | $77.44 | $21.44 |
| Resistance Level | $85.25 | $22.85 |
| Average True Range (ATR) | 3.56 | 1.27 |
| MACD | -0.32 | 0.43 |
| Stochastic Oscillator | 55.84 | 89.08 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.